Chronic kidney disease among men with lower urinary tract symptoms due to benign prostatic hyperplasia

BJU International

Volumn 105, Issue 10, 2010, Pages 1424-1428

  Hong, Sung Kyu ^a   Lee, Seung Tae ^a   Jeong, Sung Jin ^a   Byun, Seok Soo ^a   Hong, Young Kwon ^b   Park, Dong Soo ^b   Hong, Jae Yup ^b   Son, Jeong Hwan ^c   Kim, Cheil ^c   Jang, Seok Heun ^c   Lee, Sang Eun ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b Bundang CHA Hospital   (South Korea)

^c Bundang Jesaeng Hospital   (South Korea)

Author keywords

Chronic kidney failure; Creatinine; Prostate; Prostatic hyperplasia

Indexed keywords

CREATININE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FLOW RATE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY;

AGE DISTRIBUTION; AGED; DIABETES COMPLICATIONS; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATISM; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; URINE;

EID: 77951724633     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08975.x     Document Type: Article

References (23)

1. Sacks SH, Aparicio SA Bevan A, Oliver DO, Will EJ, Davison AM. Late renal failure due to prostatic outflow obstruction: a preventable disease. BMJ 1989 298 : 156 159
2. Fox CS, Larson MG, Leip EP et al. Predictors of new-onset kidney disease in a community-based population. JAMA 2004 291 : 844 850
3. McConnell JD, Barry MJ, Bruskewitz RC et al. Benign prostatic hyperplasia: diagnosis and treatment. Clinical Practice Guideline, Number 8. Agency for Health Care Policy and Research. Publication No 04-583. Rockville, Maryland: Public Health Service, United States Department of Health and Human Services, February 1994
4. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol 2003 170 : 530 547
5. Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH Guidelines). Eur Urol 2004 46 : 547 54
6. Irani J, Brown CT, van der Meulen J, Emberton M. A review of guidelines on benign prostatic hyperplasia and lower urinary tract symptoms: are all guidelines the same? BJU Int 2003 92 : 937 942
7. Rule AD, Jacobson DJ, Roberts RO et al. The association between benign prostatic hyperplasia and chronic kidney disease in community-dwelling men. Kidney Int 2005 67 : 2376 2382
8. Levey AS, Coresh J, Balk E et al. National Kidney Foundation practice guidelines for chronic kidney disease. Evaluation, classification, and stratification. Ann Intern Med 2003 139 : 137 147
9. WHO Expert Consultation. Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004 363 : 157 163
10. Koch WF, Ezz el Din K, de Wildt MJ, Debruyne FM, de la Rosette JJ. The outcome of renal ultrasound in the assessment of 556 consecutive patients with benign prostatic hyperplasia. J Urol 1996 155 : 186 189
11. Hamm RS, MacDermott SM. Renal function in men with lower urinary tract symptoms at first presentation to urology out-patient department. Ann R Coll Surg Engl 2004 86 : 182 185
12. Nissenkorn I, Savion M, Servadio C. Renal and bladder function recovery after prostatectomy in patients with a chronic residual urine of above 1,000 ml. Eur Urol 1988 14 : 434 436
13. Hill AM, Philpott N, Kay JD, Smith JC, Fellows GJ, Sacks SH. Prevalence and outcome of renal impairment at prostatectomy. Br J Urol 1993 71 : 464 8
14. Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989 141 : 243 247
15. Flanigan RC, Reda DJ, Wasson JH, Anderson RJ, Abdellatif M, Bruskewitz RC. 5-Year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study. J Urol 1998 160 : 12 6
16. Sarmina I, Resnick MI. Obstructive uropathy in patients with benign prostatic hyperplasia. J Urol 1989 141 : 866 869
17. Gerber GS, Goldfischer ER, Karrison TG, Bales GT. Serum creatinine measurements in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 1997 49 : 697 702
18. Rule AD, Lieber MM, Jacobsen SJ. Is benign prostatic hyperplasia a risk factor for chronic renal failure? J Urol 2005 173 : 691 696
19. Ponholzer A, Temml C, Obermayr RP, Rauchenwald M, Madersbacher S. The association between lower urinary tract symptoms and renal function in men: a cross-sectional and 5-year longitudinal analysis. J Urol 2006 175 : 1398 1402
20. Botker-Rasmussen I, Bagi P, Jorgensen JB. Is bladder outlet obstruction normal in elderly men without lower urinary tract symptoms? Neurourol Urodyn 1999 18 : 545 551
21. Hunter DJ, Berra-Unamuno A, Martin-Gordo A. Prevalence of urinary symptoms and other urological conditions in Spanish men 50 years old or older. J Urol 1996 155 : 1965 1970
22. Haroun MK, Bernard GJ, Hoffman SC et al. Risk factors for chronic kidney disease. A prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 2003 14 : 2934 2941
23. Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004 140 : 167 174